Comparison of Intravitreal Ranibizumab and Aflibercept in Patients With Choroidal Neovascularization in Pathologic Myopia. Ukr. j. ophthalmol. 2026, No. 5, 34-38. https://doi.org/10.31288/oftalmolzh201753438.